SEARCH

SEARCH BY CITATION

References

  • Bowen, A.R., Hanks, A.N., Allen, S.M., Alexander, A., Diedrich, M.J., and Grossman, D. (2003). Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J. Invest. Dermatol. 120, 4855.
  • Burrows, A.E., Smogorzewska, A., and Elledge, S.J. (2010). Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc. Natl Acad. Sci. USA 107, 1428014285.
  • Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L., and Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 34263439.
  • Crnkovic-Mertens, I., Hoppe-Seyler, F., and Butz, K. (2003). Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 22, 83308336.
  • Crnkovic-Mertens, I., Semzow, J., Hoppe-Seyler, F., and Butz, K. (2006). Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells. J. Mol. Med. 84, 232240.
  • Cruickshank, M., Fenwick, E., Abraham, L.J., and Ulgiati, D. (2008). Quantitative differences in chromatin accessibility across regulatory regions can be directly compared in distinct cell-types. Biochem. Biophys. Res. Commun. 367, 349355.
  • Decristofaro, M.F., Betz, B.L., Rorie, C.J., Reisman, D.N., Wang, W., and Weissman, B.E. (2001). Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J. Cell. Physiol. 186, 136145.
  • Dynek, J.N., Chan, S.M., Liu, J., Zha, J., Fairbrother, W.J., and Vucic, D. (2008). Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res. 68, 31243132.
  • Flowers, S., Nagl, N.G. Jr, Beck, G.R. Jr, and Moran, E. (2009). Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. J. Biol. Chem. 284, 1006710075.
  • Flygare, J.A., Beresini, M., Budha, N. et al. (2012). Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J. Med. Chem. 55, 41014113.
  • Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117122.
  • Gupta, P.B., Kuperwasser, C., Brunet, J.P., Ramaswamy, S., Kuo, W.L., Gray, J.W., Naber, S.P., and Weinberg, R.A. (2005). The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat. Genet. 37, 10471054.
  • Hodis, E., Watson, I.R., Kryukov, G.V. et al. (2012). A landscape of driver mutations in melanoma. Cell 150, 251263.
  • Hornyak, T.J., Jiang, S., Guzman, E.A., Scissors, B.N., Tuchinda, C., He, H., Neville, J.D., and Strickland, F.M. (2009). Mitf dosage as a primary determinant of melanocyte survival after ultraviolet irradiation. Pigment Cell Melanoma Res. 22, 307318.
  • Jhappan, C., Noonan, F.P., and Merlino, G. (2003). Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22, 30993112.
  • Kasof, G.M., and Gomes, B.C. (2001). Livin, a novel inhibitor of apoptosis protein family member. J. Biol. Chem. 276, 32383246.
  • Keenen, B., Qi, H., Saladi, S.V., Yeung, M., and de la Serna, I.L. (2010). Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma. Oncogene 29, 8192.
  • Kia, S.K., Gorski, M.M., Giannakopoulos, S., and Verrijzer, C.P. (2008). SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol. Cell. Biol. 28, 34573464.
  • Kothandapani, A., Gopalakrishnan, K., Kahali, B., Reisman, D., and Patrick, S.M. (2012). Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Exp. Cell Res. 318, 19731986.
  • Krauthammer, M., Kong, Y., Ha, B.H. et al. (2012). Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. 44, 10061014.
  • Lazar, I., Perlman, R., Lotem, M., Peretz, T., Ben-Yehuda, D., and Kadouri, L. (2012). The clinical effect of the inhibitor of apopotosis protein livin in melanoma. Oncology 82, 197204.
  • Lin, H., Wong, R.P., Martinka, M., and Li, G. (2010). BRG1 expression is increased in human cutaneous melanoma. Br. J. Dermatol. 163, 502510.
  • Liu, T.F., Kandala, G., andSetaluri, V. (2001). PDZ domain protein GIPC interacts with the cytoplasmic tail of melanosomal membrane protein gp75 (tyrosinase-related protein-1). J. Biol. Chem. 276, 3576835777.
  • Liu, B., Han, M., Wen, J.K., and Wang, L. (2007). Livin/ML-IAP as a new target for cancer treatment. Cancer Lett. 250, 168176.
  • Liu, F., Fu, Y., and Meyskens, F.L. Jr. (2009). MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J. Invest. Dermatol. 129, 422431.
  • McGill, G.G., Horstmann, M., Widlund, H.R. et al. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707718.
  • O'Riordan, M.X., Bauler, L.D., Scott, F.L., and Duckett, C.S. (2008). Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation. Dev. Cell 15, 497508.
  • Ozsolak, F., Song, J.S., Liu, X.S., and Fisher, D.E. (2007). High-throughput mapping of the chromatin structure of human promoters. Nat. Biotechnol. 25, 244248.
  • Rao, S., Procko, E., and Shannon, M.F. (2001). Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol. 167, 44944503.
  • Rouzaud, F., Kadekaro, A.L., Abdel-Malek, Z.A., and Hearing, V.J. (2005). MC1R and the response of melanocytes to ultraviolet radiation. Mutat. Res. 571, 133152.
  • Saladi, S.V., Keenen, B., Marathe, H.G., Qi, H., Chin, K.V., and de la Serna, I.L. (2010). Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness. Mol. Cancer 9, 280297.
  • Sato, S., Roberts, K., Gambino, G., Cook, A., Kouzarides, T., and Goding, C.R. (1997). CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene 14, 30833092.
  • de la Serna, I.L., Carlson, K.A., Hill, D.A., Guidi, C.J., Stephenson, R.O., Sif, S., Kingston, R.E., and Imbalzano, A.N. (2000). Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene. Mol. Cell. Biol. 20, 28392851.
  • de la Serna, I.L., Ohkawa, Y., Higashi, C., Dutta, C., Osias, J., Kommajosyula, N., Tachibana, T., and Imbalzano, A.N. (2006a). The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. J. Biol. Chem. 281, 2023320241.
  • de la Serna, I.L., Ohkawa, Y., and Imbalzano, A.N. (2006b). Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat. Rev. Genet. 7, 461473.
  • Sviderskaya, E.V., Hill, S.P., Balachandar, D., Barsh, G.S., and Bennett, D.C. (2001). Agouti signaling protein and other factors modulating differentiation and proliferation of immortal melanoblasts. Dev. Dyn. 221, 373379.
  • Varela, I., Tarpey, P., Raine, K. et al. (2011). Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539542.
  • Varfolomeev, E., Moradi, E., Dynek, J.N., Zha, J., Fedorova, A.V., Deshayes, K., Fairbrother, W.J., Newton, K., Le Couter, J., and Vucic, D. (2012). Characterization of ML-IAP protein stability and physiological role in vivo. Biochem. J. 447, 427436.
  • Vucic, D., Stennicke, H.R., Pisabarro, M.T., Salvesen, G.S., and Dixit, V.M. (2000). ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr. Biol. 10, 13591366.
  • Wilson, B.G., Wang, X., Shen, X., McKenna, E.S., Lemieux, M.E., Cho, Y.J., Koellhoffer, E.C., Pomeroy, S.L., Orkin, S.H., and Roberts, C.W. (2010). Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 18, 316328.
  • Xia, W., Nagase, S., Montia, A.G., Kalachikov, S.M., Keniry, M., Su, T., Memeo, L., Hibshoosh, H., and Parsons, R. (2008). BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer. Cancer Res. 68, 16671674.
  • Xu, Y., Zhang, J., and Chen, X. (2007). The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes. J. Biol. Chem. 282, 3742937435.
  • Yan, Z., Cui, K., Murray, D.M., Ling, C., Xue, Y., Gerstein, A., Parsons, R., Zhao, K., and Wang, W. (2005). PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev. 19, 16621667.
  • Ye, L., Song, X., Li, S., Yang, D., Zhang, J., Che, X., Chen, X., Wang, J., and Zhang, Z. (2011). Livin-alpha promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer. Prostate 71, 4251.
  • Zhao, Q., Wang, Q.E., Ray, A., Wani, G., Han, C., Milum, K., and Wani, A.A. (2009). Modulation of nucleotide excision repair by mammalian SWI/SNF chromatin-remodeling complex. J. Biol. Chem. 284, 3042430432.